2,6-xylidine has been researched along with Hypertrophy in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hirose, M; Kobayashi, H; Koujitani, T; Mitsumori, K; Onodera, H; Shimamura, Y; Takagi, H; Yasuhara, K | 1 |
1 other study(ies) available for 2,6-xylidine and Hypertrophy
Article | Year |
---|---|
Toxicity and blood concentrations of xylazine and its metabolite, 2,6-dimethylaniline, in rats after single or continuous oral administrations.
Topics: Administration, Oral; Aniline Compounds; Animals; Drug Administration Schedule; Hypertrophy; Male; Maximum Tolerated Dose; Nasal Cavity; Olfactory Mucosa; Rats; Rats, Inbred F344; Thyroid Gland; Xylazine | 2000 |